Flow/volume (F/V) spirometry is routinely used for assessing the type and s
everity of lung disease. Forced vital capacity (FVC) and timed vital capaci
ty (FEV1) provide the best estimates of airflow obstruction in patients wit
h asthma, chronic obstructive pulmonary disease (COPD) and emphysema. Compu
terized spirometers are now available for early home recognition of asthma
exacerbation in high risk patients with severe persistent disease, and for
recognition of either infection or rejection in lung transplant patients.
Patients with severe COPD may exhibit expiratory flow limitation (EFL) on t
idal volume (VT) expiratory F/V (VTF/V) curves, either with or without appl
ying negative expiratory pressure (NEP). EFL results in dynamic hyperinflat
ion and persistently raised alveolar pressure or intrinsic PEEP (PEEPi). Hy
perinflation and raised PEEPi greatly enhance dyspnea with exertion through
the added work of the threshold load needed to overcome raised pleural pre
ssure. Esophageal (pleural) pressure monitoring may be added to VTF/V loops
for assessing the severity of PEEPi: 1) to optimize assisted ventilation b
y mask or via endotracheal tube with high inspiratory flow rates to lower I
: E ratio, and 2) to assess the efficacy of either pressure support ventil
ation (PSV) or low level extrinsic PEEP in reducing the threshold load of P
EEPi. Intraoperative tidal volume F/V loops can also be used to document th
e efficacy of emphysema lung volume reduction surgery (LVRS) via disappeara
nce of EFL.
Finally, the mechanism of ventilatory constraint can be identified with the
use of exercise tidal volume F/V loops referenced to maximum F/V loops and
static lung volumes. Patients with severe COPD show inspiratory F/V loops
approaching 95% of total lung capacity, and flow limitation over the entire
expiratory F/V curve during light levels of exercise. Surprisingly, patien
ts with a history of congestive heart failure may lower lung volume towards
residual volume during exercise, thereby reducing airway diameter and indu
cing expiratory flow limitation.